Cyclooxygenase Inhibitors Flashcards
4 types of analgesic product
aspirin
ibuprofen
naproxen
acetaminophen
COX-1 (good COX) targets
- Platelets: synthesis of TXA2 which stimulates platelet aggregation
- Stomach: synthesis of PGE2 and PGI2 which are gastroprotective
- Kidneys: synthesis of PGE2 and PGI2 which stimulate renal vasodilation and blood flow
Effects of COX-2 (bad COX)
- inflammation, pain, fever
- uterus contractions at term
- bronchial smooth muscle relaxation
Aspirin is a unique first generation NSAID in that..
COX inhibition is irreversible
Protection against CV events due to COX-1 inhibition
Therapeutic Uses of Aspirin
a. anti-inflammatory (high doses - 4-6g/day)
b. analgesic (325-1000mg, 3-4x/day)
c. antipyretic (325-1000mg, 3-4x/day)
d. dysmenorrhea (325-1000mg, 3-4x/day)
e. antiplatelet* (81mg daily)
Reye’s syndrome
complication with the use of Aspirin in children under 18 years old
causes encephalopathy and fatty liver
greatest risk if used post-viral illness
Hypersensitivity reaction in the use of NSAIDs
inhibition of COX results in shunting of production away from prostaglandins towards leukotrienes
leukotrienes cause bronchial constriction
ASA contraindications
- peptic ulcer disease
- bleeding disorders
- NSAID hypersensitivity
- under 18yo
- 3rd trimester of pregnancy
3 key exceptions of side effects of OTHER first generation NSAIDs vs Aspirin
- risk of CV even is increased
- no salicylism
- not linked to Reye’s syndrome
Salicylism
results from creation of salicylate compounds causing tinnitus, sweating, headache and dizziness
only with aspirin
Second generation NSAIDs
selectively inhibits COX-2
Side effects of coxibs (second generation NSAIDs)
a. GI ulceration
b. HIGHEST risk of CV events
NSAIDs and Hypertension
may cause or exacerbate HTN
- causes edema and fluid retention
acetaminophen
inhibition of COX in CNS, not periphery
- analgesic, antipyretic
- NO anti-inflammatory activity
- NO effect on kidneys or platelets
- can cause liver toxicity when overdosed
Metabolic pathways of Acetaminophen
a. major pathway
- conjugated to form nontoxic metabolites
b. minor pathway
- converted into toxic metabolite by CYP450»_space; converted into non-toxic form by glutathione